🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to determine the incremental intraocular pres...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-09-21
Trial ID
NCT03150160
The proposed crossover study will compare for the first time the quality of...
Status
Completed
Location
Multiple Locations
Start Date
2009-08
Trial ID
NCT00981786
The purpose of this study was to compare the short term effects of two intr...
Status
Completed
Location
Contact Alcon Call Center at 1-888-451-3937 For Trial Locations
Start Date
2009-02
Trial ID
NCT00800540
This study aims to evaluate the effect of fixed brinzolamide-brimonidine co...
Status
Completed
Location
University Hospital of Patras
Start Date
2017-09-04
Trial ID
NCT03494257
Treatments Being Tested
The purpose of this study was to evaluate the safety and efficacy of Brinzo...
Status
Completed
Location
Multiple Locations
Start Date
2011-05
Trial ID
NCT01309204
The purpose of this study was to evaluate the efficacy and safety of a fixe...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01297517
The purpose of this study was to compare the safety and intraocular pressur...
Status
Terminated
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT00961649
The purpose of this study is to evaluate intraocular pressure (IOP) over a ...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01978600
Treatments Being Tested
The purpose of this study was to describe the ocular discomfort immediately...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01426867
Glaucoma is one of the leading causes of blindness worldwide that is a chro...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT03966560